Resources Contact Us Home
Modified factor VIII

Image Number 3 for United States Patent #7012132.

Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more of the specific loci. The modified factor VIII is not inhibited by inhibitory antibodies against the A2 or C2 domain epitopes. The modified factor VIII is useful for hemophiliacs, either to avoid or prevent the action of inhibitory antibodies.

  Recently Added Patents
Permeable pressure sensitive adhesive
System and method to assess and report the health of landing gear related components
Arcuate motion control in electrostatic actuators
Cantilevered probe detector with piezoelectric element
System and method for enhanced artificial bandwidth expansion
Semiconductor devices having multi-width isolation layer structures
Centralized behavioral information system
  Randomly Featured Patents
Method of restricting scheduling request for effective data transmission
Automatic sample changer
Method for determining periodontal disease
Herbicidal 1,2,4-benzotriazines
Flat type cathode ray tube and color image display apparatus utilizing same
Selecting and routing sub-signals from a common signal path
Process of manufacturing a gas-generating cleaning material
Electrolytic igniter for rocket engines using monopropellants
Integrated electrical/communication system hardware
Tripoint plectrum for string instruments